{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T17:54:32Z","timestamp":1759773272515},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T00:00:00Z","timestamp":1429660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s40618-015-0278-7","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T05:53:51Z","timestamp":1429595631000},"page":"1167-1173","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serum prolidase levels in Graves\u2019 disease without ophthalmopathy and its association with oxidative status"],"prefix":"10.1007","volume":"38","author":[{"given":"H.","family":"Korkmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tabur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ozkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Oguz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Akarsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,22]]},"reference":[{"key":"278_CR1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.autrev.2014.01.013","volume":"13","author":"F Menconi","year":"2014","unstructured":"Menconi F, Marcocci C, Marin\u00f2 M (2014) Diagnosis and classification of Graves\u2019 disease. Autoimmun Rev 13:398\u2013402","journal-title":"Autoimmun Rev"},{"key":"278_CR2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/ICU.0b013e3283499446","volume":"22","author":"RS Douglas","year":"2011","unstructured":"Douglas RS, Gupta S (2011) The pathophysiology of thyroid eye disease: implications for immunotherapy. Curr Opin Ophthalmol 22:385\u2013390","journal-title":"Curr Opin Ophthalmol"},{"key":"278_CR3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40618-014-0214-2","volume":"38","author":"M Marin\u00f2","year":"2015","unstructured":"Marin\u00f2 M, Latrofa F, Menconi F, Chiovato L, Vitti P (2015) Role of genetic and non-genetic factors in the etiology of Graves\u2019 disease. J Endocrinol Invest 38:283\u2013294","journal-title":"J Endocrinol Invest"},{"key":"278_CR4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/138920211798120844","volume":"12","author":"O Khalilzadeh","year":"2011","unstructured":"Khalilzadeh O, Noshad S, Rashidi A, Amirzargar A (2011) Graves\u2019 ophthalmopathy: a review of immunogenetics. Curr Genomics 12:564\u2013575","journal-title":"Curr Genomics"},{"key":"278_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clinbiochem.2013.08.002","volume":"47","author":"K Winsz-Szczotka","year":"2014","unstructured":"Winsz-Szczotka K, Komosi\u0144ska-Vassev K, Ku\u017anik-Trocha K, Olczyk K (2014) Antioxidant activity and structural modifications of serum chondroitin sulfate in Graves\u2019 disease. Clin Biochem 47:19\u201324","journal-title":"Clin Biochem"},{"key":"278_CR6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2613.2006.00486.x","volume":"87","author":"M Cechowska-Pasko","year":"2006","unstructured":"Cechowska-Pasko M, Pa\u0142ka J, Wojtukiewicz MZ (2006) Enhanced prolidase activity and decreased collagen content in breast cancer tissue. Int J Exp Pathol 87:289\u2013296","journal-title":"Int J Exp Pathol"},{"key":"278_CR7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcla.20334","volume":"24","author":"M Horoz","year":"2010","unstructured":"Horoz M, Aslan M, Bolukbas FF, Bolukbas C, Nazligul Y, Celik H, Aksoy N (2010) Serum prolidase enzyme activity and its relation to histopathological findings in patients with non-alcoholic steatohepatitis. J Clin Lab Anal 24:207\u2013211","journal-title":"J Clin Lab Anal"},{"key":"278_CR8","author":"M Zarkovi\u0107","year":"2012","unstructured":"Zarkovi\u0107 M (2012) The role of oxidative stress on the pathogenesis of Graves\u2019 disease. J Thyroid Res. doi: 10.1155\/2012\/302537","journal-title":"J Thyroid Res"},{"key":"278_CR9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clinbiochem.2003.10.014","volume":"37","author":"O Erel","year":"2004","unstructured":"Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112\u2013119","journal-title":"Clin Biochem"},{"key":"278_CR10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.clinbiochem.2005.08.008","volume":"38","author":"O Erel","year":"2005","unstructured":"Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103\u20131111","journal-title":"Clin Biochem"},{"key":"278_CR11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1442-200x.2005.02137.x","volume":"47","author":"A Aycicek","year":"2005","unstructured":"Aycicek A, Erel O, Kocyigit A (2005) Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers. Pediatr Int 47:635\u2013639","journal-title":"Pediatr Int"},{"key":"278_CR12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70\u201377","journal-title":"Arch Biochem Biophys"},{"key":"278_CR13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0009-8981(82)90196-6","volume":"125","author":"I Myara","year":"1982","unstructured":"Myara I, Charpentier C, Lemonnier A (1982) Optimal conditions for prolidase assay by proline colorimetric determination: application to imminodipeptiduria. Clin Chim Acta 125:193\u2013205","journal-title":"Clin Chim Acta"},{"key":"278_CR14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-9258(18)44814-4","volume":"199","author":"FP Chinard","year":"1952","unstructured":"Chinard FP (1952) Photometric estimation of proline and ornithine. J Biol Chem 199:91\u201395","journal-title":"J Biol Chem"},{"key":"278_CR15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","volume":"92","author":"R Visse","year":"2003","unstructured":"Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827\u2013839","journal-title":"Circ Res"},{"key":"278_CR16","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2174\/092986710793213724","volume":"17","author":"O Zitka","year":"2010","unstructured":"Zitka O, Kukacka J, Krizkova S, Huska D, Adam V, Masarik M, Prusa R, Kizek R (2010) Matrix metalloproteinases. Curr Med Chem 17:3751\u20133768","journal-title":"Curr Med Chem"},{"key":"278_CR17","author":"SM Galil","year":"2014","unstructured":"Galil SM, El-Shafey AM, Hagrass HA, Fawzy F, Sammak AE (2014) Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients. Int J Rheum Dis. doi: 10.1111\/1756-185X.12434","journal-title":"Int J Rheum Dis"},{"key":"278_CR18","first-page":"2804","volume":"7","author":"M Odabasi","year":"2014","unstructured":"Odabasi M, Yesil A, Ozkara S, Paker N, Ozkan S, Eris C, Yildiz MK, Abuoglu HH, Gunay E, Teke\u015fin K (2014) Role of human neutrophil gelatinase associated lipocalin (NGAL) and Matrix Metalloproteinase-9 (MMP-9) overexpression in neoplastic colon polyps. Int J Clin Exp Med 7:2804\u20132811","journal-title":"Int J Clin Exp Med"},{"key":"278_CR19","doi-asserted-by":"crossref","unstructured":"Beaudeux JL, Giral P, Bruckert E, Foglietti MJ, Chapman MJ (2004) Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives. Clin Chem Lab Med 42:121e31","DOI":"10.1515\/CCLM.2004.024"},{"key":"278_CR20","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/rheumatology\/keh369","volume":"43","author":"J Hulkkonen","year":"2004","unstructured":"Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M, P\u00f6ll\u00e4nen P, Lehtim\u00e4ki T (2004) Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren\u2019s syndrome. Rheumatology (Oxford) 43:1476\u20131479","journal-title":"Rheumatology (Oxford)"},{"key":"278_CR21","first-page":"105","volume":"58","author":"J My\u015bliwiec","year":"2007","unstructured":"My\u015bliwiec J, Adamczyk M, Paw\u0142owski P, Niko\u0142ajuk A, G\u00f3rska M (2007) Serum gelatinases (MMP-2 and MMP-9) and VCAM-1 as a guideline in a therapeutic approach in Graves\u2019 ophthalmopathy. Endokrynol Pol 58:105\u2013109","journal-title":"Endokrynol Pol"},{"key":"278_CR22","first-page":"15","volume":"36","author":"C Marcocci","year":"2013","unstructured":"Marcocci C, Bartalena L (2013) Role of oxidative stress and selenium in Graves\u2019 hyperthyroidism and orbitopathy. J Endocrinol Invest 36:15\u201320","journal-title":"J Endocrinol Invest"},{"key":"278_CR23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00296-006-0247-8","volume":"27","author":"O Altindag","year":"2007","unstructured":"Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M (2007) Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int 27:339\u2013344","journal-title":"Rheumatol Int"},{"key":"278_CR24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/cen.12110","volume":"79","author":"N Hilali","year":"2013","unstructured":"Hilali N, Vural M, Camuzcuoglu H, Camuzcuoglu A, Aksoy N (2013) Increased prolidase activity and oxidative stress in PCOS. Clin Endocrinol (Oxf) 79:105\u2013110","journal-title":"Clin Endocrinol (Oxf)"},{"key":"278_CR25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00432-011-1136-4","volume":"138","author":"I Gecit","year":"2012","unstructured":"Gecit I, Aslan M, Gunes M, Pirincci N, Esen R, Demir H, Ceylan K (2012) Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer. J Cancer Res Clin Oncol 138:739\u2013743","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0278-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0278-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T16:19:57Z","timestamp":1651767597000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0278-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,22]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["278"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0278-7","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,22]]}}}